AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
最新の財務諸表(Form-10K)によると、Petro USA Incの総資産は$0で、純損失は$0です。
ADDLFの主要な財務比率は何ですか?
Petro USA Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
AddLife AB (publ)の収益はセグメントまたは地域別にどのように分けられていますか?
Petro USA Inc の最大収益セグメントは Automotive Seating Supply で、最新の利益発表における収益は 14,535,000,000 です。地域別に見ると、United States が Petro USA Inc の主要市場であり、収益は 6,140,000,000 です。